DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 145 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $431,742 | +75379.4% | 33,942 | -16.5% | 0.03% | -17.6% |
| Q2 2023 | $572 | -45.2% | 40,643 | -39.8% | 0.03% | -46.9% |
| Q1 2023 | $1,043 | -8.3% | 67,524 | -2.7% | 0.06% | -8.6% |
| Q4 2022 | $1,138 | -99.9% | 69,405 | -30.3% | 0.07% | -42.1% |
| Q3 2022 | $1,841,000 | +35.6% | 99,533 | -3.6% | 0.12% | +44.0% |
| Q2 2022 | $1,358,000 | +44.2% | 103,235 | +1.6% | 0.08% | +68.0% |
| Q1 2022 | $942,000 | +8.8% | 101,643 | +14.7% | 0.05% | +16.3% |
| Q4 2021 | $866,000 | -63.4% | 88,628 | +27.4% | 0.04% | -65.3% |
| Q3 2021 | $2,363,000 | +3.1% | 69,541 | +11.1% | 0.12% | +1.6% |
| Q2 2021 | $2,291,000 | +25.5% | 62,577 | +53.7% | 0.12% | +10.9% |
| Q1 2021 | $1,826,000 | – | 40,723 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |